RDNT vs USPH

For growth investors, U.

S. Physical Therapy, Inc. (USPH) is the stronger pick with 16. 3% revenue growth year-over-year, versus 11. 5% for RadNet, Inc. (RDNT). U. S. Physical Therapy, Inc. (USPH) offers the better valuation at 41. 5x trailing P/E (20. 6x forward), making it the more compelling value choice. Analysts rate RadNet, Inc. (RDNT) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, U.

S. Physical Therapy, Inc. is actually cheaper at 20. 6x.

Over the past 5 years, RadNet, Inc.

(RDNT) delivered a total return of +147. 1%, compared to -43. 4% for U. S. Physical Therapy, Inc. (USPH). Over 10 years, the gap is even starker: RDNT returned +947. 4% versus USPH's +22. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), U.

S. Physical Therapy, Inc. (USPH) is the lower-risk stock at 0. 93β versus RadNet, Inc. 's 1. 43β — meaning RDNT is approximately 53% more volatile than USPH relative to the S&P 500. On balance sheet safety, U. S. Physical Therapy, Inc. (USPH) carries a lower debt/equity ratio of 55% versus 137% for RadNet, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), U.

S. Physical Therapy, Inc. (USPH) is pulling ahead at 16. 3% versus 11. 5% for RadNet, Inc. (RDNT). On earnings-per-share growth, the picture is similar: U. S. Physical Therapy, Inc. grew EPS -22. 8% year-over-year, compared to -768. 4% for RadNet, Inc.. Over a 3-year CAGR, RDNT leads at 12. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

RadNet, Inc.

(RDNT) is the more profitable company, earning 2. 3% net margin versus 1. 9% for U. S. Physical Therapy, Inc. — meaning it keeps 2. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: USPH leads at 10. 3% versus 3. 0% for RDNT. At the gross margin level — before operating expenses — USPH leads at 20. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, U.

S. Physical Therapy, Inc. (USPH) trades at 20. 6x forward P/E versus 91. 8x for RadNet, Inc. — 71. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USPH: 72. 9% to $102. 00.

In this comparison, USPH (3.

1% yield) pays a dividend. RDNT does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, U.

S. Physical Therapy, Inc. (USPH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 93), 3. 1% yield). Both have compounded well over 10 years (USPH: +22. 6%, RDNT: +947. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: RDNT is a small-cap quality compounder stock; USPH is a small-cap high-growth stock. USPH pays a dividend while RDNT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.